Moderna, Inc.
Close on Nov 2, 2026Market cap $88.16BP/E –Yield –
Moderna Cumulative participant enrollment in Phase 3 by Year
Cumulative participant enrollment in Phase 3 registrational trials (participants)
Moderna Cumulative participant enrollment in Phase 3: 325,881.00 participants in FY2025, up 28.6% from a year earlier. That is the highest of the 8 years on record here.
Where the FY2025 figure comes from
Source: ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗
Reported in ClinicalTrials.gov API v2 (ModernaTX, Inc.).
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | Cumulative participant enrollment in Phase 3 registrational trials (participants) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 325,881.00 | +28.6% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2024 | Dec 31, 2024 | 253,482.00 | +49.8% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2023 | Dec 31, 2023 | 169,269.00 | +26.1% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2022 | Dec 31, 2022 | 134,234.00 | +38.4% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2021 | Dec 31, 2021 | 96,958.00 | +179.1% | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2020 | Dec 31, 2020 | 34,743.00 | – | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2019 | Dec 31, 2019 | 0.00 | – | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
| FY2018 | Dec 31, 2018 | 0.00 | – | ClinicalTrials.gov API v2 (ModernaTX, Inc.) ↗ |
Cite this data
StockData. (2026). Moderna Cumulative participant enrollment in Phase 3, annual FY2018–FY2025 [Data set]. Compiled from Moderna SEC filings and investor materials. https://stockdatahq.com/stocks/mrna/kpis/ctgov-cum-phase3-enrollment
See every metric in the Moderna KPI table. Data updated Nov 3, 2026.